M

Medicon Hellas SA
ATHEX:MEDIC

Watchlist Manager
Medicon Hellas SA
ATHEX:MEDIC
Watchlist
Price: 2.72 EUR 0.74% Market Closed
Market Cap: €12m

Operating Margin

12%
Current
Improving
by 0.3%
vs 3-y average of 11.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
12%
=
Operating Income
€2.2m
/
Revenue
€18.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
12%
=
Operating Income
€2.2m
/
Revenue
€18.3m

Peer Comparison

Country Company Market Cap Operating
Margin
GR
Medicon Hellas SA
ATHEX:MEDIC
12m EUR
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.3B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
187.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.8B USD
Loading...
US
Stryker Corp
NYSE:SYK
135B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
59.2B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.5B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.6B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.6B USD
Loading...

Market Distribution

In line with most companies in Greece
Percentile
50th
Based on 330 companies
50th percentile
12%
Low
-1 006.6% — 4.1%
Typical Range
4.1% — 20.3%
High
20.3% — 139.8%
Distribution Statistics
Greece
Min -1 006.6%
30th Percentile 4.1%
Median 11.9%
70th Percentile 20.3%
Max 139.8%

Medicon Hellas SA
Glance View

Market Cap
12m EUR
Industry
Health Care

Medicon Hellas SA engages in the business of medical technology. The company is headquartered in Athina, Attiki. The company went IPO on 2001-07-11. Its activities include research and development, production, and import and export of diagnostic products; the development of laboratory information systems; the import and distribution of in vitro diagnostics and automated analytical systems, such as Olympus for clinical chemistry, immunochemistry and lab automation, and Nihon Kohden for hematology, and the provision of cosmetic and body care products, such as make-up, anti-ageing and skin care products under the brand name Miss Beaute. Its laboratory information systems products include: Gi-Lab, which is a management system for medical laboratories; Gi-Maxima, a management program for medical centers, and Gi-Blood, which is an application that helps to connect various blood donation networks. On December 6, 2013, it merged by absorption of its subsidiary, Medicon Ltd.

MEDIC Intrinsic Value
5.95 EUR
Undervaluation 54%
Intrinsic Value
Price
M
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
12%
=
Operating Income
€2.2m
/
Revenue
€18.3m
What is Medicon Hellas SA's current Operating Margin?

The current Operating Margin for Medicon Hellas SA is 12%, which is above its 3-year median of 11.7%.

How has Operating Margin changed over time?

Over the last 3 years, Medicon Hellas SA’s Operating Margin has decreased from 20% to 12%. During this period, it reached a low of 5.4% on Jun 30, 2024 and a high of 20% on May 30, 2022.

Back to Top